Furthermore, since increased levels of IL-2, IL-8, IL-17, G-CSF, MCP-1, MIP-1α, and VEGF were previously identified in the CSF of ALS patients13, these molecules emerge as shared neuroinflammatory signatures across motor neuron diseases14–16. Here, IL17A is linked to amyotrophic lateral sclerosis.